MeiLan K. Han

878 total citations
13 papers, 589 citations indexed

About

MeiLan K. Han is a scholar working on Pulmonary and Respiratory Medicine, General Health Professions and Issues, ethics and legal aspects. According to data from OpenAlex, MeiLan K. Han has authored 13 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 2 papers in General Health Professions and 2 papers in Issues, ethics and legal aspects. Recurrent topics in MeiLan K. Han's work include Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Respiratory Support and Mechanisms (4 papers) and Pulmonary Hypertension Research and Treatments (2 papers). MeiLan K. Han is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Respiratory Support and Mechanisms (4 papers) and Pulmonary Hypertension Research and Treatments (2 papers). MeiLan K. Han collaborates with scholars based in United States, United Kingdom and South Korea. MeiLan K. Han's co-authors include Fernando J. Martínez, David M. Mannino, Sarah Landis, Masakazu Ichinose, Lyrica X. Liu, Galen B. Toews, Barry H. Gross, Charlene D. Fell, Susan Murray and William D. Travis and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Respiratory Research.

In The Last Decade

MeiLan K. Han

11 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MeiLan K. Han United States 9 502 216 59 47 40 13 589
Dolores Moreno Venezuela 14 521 1.0× 280 1.3× 61 1.0× 69 1.5× 41 1.0× 32 663
Netsanet A. Negewo Australia 6 339 0.7× 195 0.9× 67 1.1× 48 1.0× 26 0.7× 9 458
Daniel Obaseki Nigeria 12 331 0.7× 147 0.7× 77 1.3× 63 1.3× 34 0.8× 33 529
Malin Fagerås Sweden 12 626 1.2× 656 3.0× 57 1.0× 76 1.6× 10 0.3× 33 941
Dmitry Galkin United States 9 327 0.7× 286 1.3× 72 1.2× 49 1.0× 11 0.3× 17 482
SF Paul Man Canada 11 416 0.8× 239 1.1× 60 1.0× 41 0.9× 20 0.5× 15 606
Edmond L. Toy United States 6 396 0.8× 215 1.0× 58 1.0× 17 0.4× 36 0.9× 9 549
Mohammad S. Dairi Saudi Arabia 7 192 0.4× 158 0.7× 38 0.6× 31 0.7× 47 1.2× 24 333
Josep M Antó Spain 7 240 0.5× 194 0.9× 54 0.9× 40 0.9× 24 0.6× 13 469
Deepa Raghavan United States 8 251 0.5× 79 0.4× 41 0.7× 15 0.3× 26 0.7× 14 346

Countries citing papers authored by MeiLan K. Han

Since Specialization
Citations

This map shows the geographic impact of MeiLan K. Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MeiLan K. Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MeiLan K. Han more than expected).

Fields of papers citing papers by MeiLan K. Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MeiLan K. Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MeiLan K. Han. The network helps show where MeiLan K. Han may publish in the future.

Co-authorship network of co-authors of MeiLan K. Han

This figure shows the co-authorship network connecting the top 25 collaborators of MeiLan K. Han. A scholar is included among the top collaborators of MeiLan K. Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MeiLan K. Han. MeiLan K. Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Fortis, Spyridon, Matthew Strand, Surya P. Bhatt, et al.. (2025). Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry. American Journal of Respiratory and Critical Care Medicine. 211(6). 957–965.
2.
Cadham, Christopher J., Nathan Cobb, MeiLan K. Han, et al.. (2025). Lung Cancer Risk in US Adults with COPD: A Systematic Review and Meta-Analysis. International Journal of COPD. Volume 20. 3399–3421.
3.
Kim, Sang Hyuk & MeiLan K. Han. (2025). Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD. Tuberculosis & respiratory diseases. 88(3). 413–418. 3 indexed citations
4.
Singh, Dave, Fernando J. Martínez, John R. Hurst, et al.. (2024). Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS). American Journal of Respiratory and Critical Care Medicine. 211(2). 205–214. 10 indexed citations
5.
Putcha, Nirupama, Trishul Siddharthan, Aaron Baugh, et al.. (2024). Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in Chronic Obstructive Pulmonary Disease?. American Journal of Respiratory and Critical Care Medicine. 210(11). 1300–1307. 4 indexed citations
6.
Singh, Dave, Gerard J. Criner, Mark T. Dransfield, et al.. (2021). InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations. Respiratory Research. 22(1). 130–130. 16 indexed citations
7.
Foo, Jason, Sarah Landis, Joe Maskell, et al.. (2016). Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries. PLoS ONE. 11(4). e0152618–e0152618. 120 indexed citations
8.
Freeman, Christine M., Alexandra L. McCubbrey, Joshua D. Nelson, et al.. (2014). Basal Gene Expression by Lung CD4+ T Cells in Chronic Obstructive Pulmonary Disease Identifies Independent Molecular Correlates of Airflow Obstruction and Emphysema Extent. PLoS ONE. 9(5). e96421–e96421. 19 indexed citations
9.
Han, MeiLan K., Elizabeth D. Bacci, David M. Mannino, et al.. (2014). Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 2(2). 103–121. 32 indexed citations
10.
Martínez, Carlos H., Beth St. Jean, Craig Plauschinat, et al.. (2014). Internet access and use by COPD patients in the National Emphysema/COPD Association Survey. BMC Pulmonary Medicine. 14(1). 66–66. 28 indexed citations
11.
Hollingworth, Kate, Kourtney J. Davis, Sarah Landis, et al.. (2014). Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013. International Journal of COPD. 9. 597–597. 117 indexed citations
12.
Freeman, Christine M., Fernando J. Martínez, MeiLan K. Han, et al.. (2013). Lung CD8+ T cells in COPD have increased expression of bacterial TLRs. Respiratory Research. 14(1). 13–13. 59 indexed citations
13.
Fell, Charlene D., Fernando J. Martínez, Lyrica X. Liu, et al.. (2010). Clinical Predictors of a Diagnosis of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 181(8). 832–837. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026